» Articles » PMID: 38563382

Enantiomer-Specific Cardiovascular Effects of the Ketone Body 3-Hydroxybutyrate

Abstract

Background: The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output (CO) by 35% to 40% in healthy people and people with heart failure. The mechanisms underlying the effects of 3-OHB on myocardial contractility and loading conditions as well as the cardiovascular effects of its enantiomeric forms, D-3-OHB and L-3-OHB, remain undetermined.

Methods And Results: Three groups of 8 pigs each underwent a randomized, crossover study. The groups received 3-hour infusions of either D/L-3-OHB (racemic mixture), 100% L-3-OHB, 100% D-3-OHB, versus an isovolumic control. The animals were monitored with pulmonary artery catheter, left ventricle pressure-volume catheter, and arterial and coronary sinus blood samples. Myocardial biopsies were evaluated with high-resolution respirometry, coronary arteries with isometric myography, and myocardial kinetics with D-[C]3-OHB and L-[C]3-OHB positron emission tomography. All three 3-OHB infusions increased 3-OHB levels (<0.001). D/L-3-OHB and L-3-OHB increased CO by 2.7 L/min (<0.003). D-3-OHB increased CO nonsignificantly (=0.2). Circulating 3-OHB levels correlated with CO for both enantiomers (<0.001). The CO increase was mediated through arterial elastance (afterload) reduction, whereas contractility and preload were unchanged. Ex vivo, D- and L-3-OHB dilated coronary arteries equally. The mitochondrial respiratory capacity remained unaffected. The myocardial 3-OHB extraction increased only during the D- and D/L-3-OHB infusions. D-[C]3-OHB showed rapid cardiac uptake and metabolism, whereas L-[C]3-OHB demonstrated much slower pharmacokinetics.

Conclusions: 3-OHB increased CO by reducing afterload. L-3-OHB exerted a stronger hemodynamic response than D-3-OHB due to higher circulating 3-OHB levels. There was a dissocitation between the myocardial metabolism and hemodynamic effects of the enantiomers, highlighting L-3-OHB as a potent cardiovascular agent with strong hemodynamic effects.

Citing Articles

Myocardial metabolic flexibility following ketone infusion demonstrated by hyperpolarized [2-C]pyruvate MRS in pigs.

Bech S, Hansen E, Nielsen B, Wiggers H, Bengtsen M, Laustsen C Sci Rep. 2025; 15(1):5849.

PMID: 39966569 PMC: 11836332. DOI: 10.1038/s41598-025-90215-9.


Cardiovascular effects of lactate in healthy adults.

Berg-Hansen K, Gopalasingam N, Pedersen M, Nyvad J, Rittig N, Sondergaard E Crit Care. 2025; 29(1):30.

PMID: 39825426 PMC: 11740418. DOI: 10.1186/s13054-025-05259-0.

References
1.
Soto-Mota A, Norwitz N, Evans R, Clarke K, Barber T . Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control. Endocrinol Diabetes Metab. 2021; 4(3):e00264. PMC: 8279633. DOI: 10.1002/edm2.264. View

2.
Nielsen R, Moller N, Gormsen L, Tolbod L, Hansson N, Sorensen J . Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation. 2019; 139(18):2129-2141. PMC: 6493702. DOI: 10.1161/CIRCULATIONAHA.118.036459. View

3.
Ho K, Karwi Q, Wagg C, Zhang L, Vo K, Altamimi T . Ketones can become the major fuel source for the heart but do not increase cardiac efficiency. Cardiovasc Res. 2020; 117(4):1178-1187. PMC: 7982999. DOI: 10.1093/cvr/cvaa143. View

4.
Ho K, Zhang L, Wagg C, Al Batran R, Gopal K, Levasseur J . Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. Cardiovasc Res. 2019; 115(11):1606-1616. PMC: 6704391. DOI: 10.1093/cvr/cvz045. View

5.
Drandarov K, Schubiger P, Westera G . Automated no-carrier-added synthesis of [1-11C]-labeled D- and L-enantiomers of lactic acid. Appl Radiat Isot. 2006; 64(12):1613-22. DOI: 10.1016/j.apradiso.2006.05.013. View